Socioeconomic disparities in cancer survival: Relation to stage at diagnosis, treatment, and centralization of patients to accredited hospitals, 2005-2014, Japan.
Israel Terungwa AgakuTakahiro TabuchiTomoki NakayaToshitaka MorishimaKayo NakataYoshihiro KuwabaraMari Kajiwara SaitoChaochen MaIsao MiyashiroPublished in: Cancer medicine (2022)
During 2005-2014, the most deprived ADI quartile had lower rates than the least deprived quartile for early-stage detection (42.6% vs. 48.7%); receipt of surgery (58.1% vs. 64.1%); and utilization of ACH (83.5% vs. 88.4%). While rate differences decreased for receipt of surgery and utilization of ACH (Annual Percent Change = -3.2 and - 11.9, respectively) over time, it remained unchanged for early-stage detection. During 2012-2014, the most deprived ADI quartile had lower 3-year survival than the least deprived (59.0% vs. 69.4%) and higher mortality (Hazard Ratio [HR] = 1.32, adjusted for case-mix): this attenuated with additional adjustment for stage at diagnosis (HR = 1.23); treatment modality (HR = 1.20); and utilization of ACH (HR = 1.19) CONCLUSIONS: Despite improvements in equalizing access to quality cancer care during 2005-2014, survival disparities remained. Interventions to reduce inequalities in early-stage detection could ameliorate such gaps.
Keyphrases
- early stage
- minimally invasive
- end stage renal disease
- loop mediated isothermal amplification
- coronary artery bypass
- sentinel lymph node
- real time pcr
- ejection fraction
- chronic kidney disease
- prognostic factors
- papillary thyroid
- peritoneal dialysis
- coronary artery disease
- radiation therapy
- young adults
- percutaneous coronary intervention
- atrial fibrillation
- replacement therapy
- acute coronary syndrome
- lymph node metastasis
- lymph node
- smoking cessation
- affordable care act
- rectal cancer